Metabolic syndrome and urinary cGMP excretion in general population

详细信息	查看全文 | 推荐本文 |

• 作者：Renzhe Cui ; Hiroyasu Iso ; Jingbo Pi ; Yoshito Kumagai ; Kazumasa Yamagishi ; Takeshi Tanigawa ; Takashi Shimamoto
• 关键词：cGMP ; Nitric oxide ; Metabolic syndrome ; Cross-sectional studies
• 刊名：Atherosclerosis
• 出版年：2007
• 期刊代码：28_00219150
• 类别：med
• 出版时间：February 2007
• 卷：190
• 期：2
• 页码：423-428
• 文件大小：138 K

摘要

To examine the relationship between metabolic syndrome and endothelial dysfunction, we investigated cross-sectionally the correlation between metabolic risk factors and urinary excretion of cyclic guanosine 3′,5′-monophosphate (cGMP), a second messenger of nitric oxide (NO), in 1541 Japanese men and women aged 40–79 years. The 24-h urinary excretion of cGMP was measured using a ¹²⁵I-labeled cGMP radioimmunoassay and was adjusted for urinary creatinine excretion (nmol/mmol creatinine). The components of metabolic syndrome were defined based on the following criteria: body mass index (BMI) ≥ 25.0 kg/m², fasting plasma glucose ≥ 6.11 mmol/l or non-fasting plasma glucose level ≥ 11.1 mmol/l, systolic blood pressure ≥ 130 mm Hg or diastolic blood pressure ≥ 85 mm Hg, high-density lipoprotein (HDL)-cholesterol < 1.03 mmol/l for men and <1.29 mmol/l for women, and triglyceride ≥ 1.69 mmol/l. The number of components of metabolic syndrome correlated inversely with urinary cGMP excretion; means of cGMP excretion for the whole group adjusted for age, sex, and cardiovascular risk factors were 53.6, 48.6, 47.9, 44.4 and 42.3 nmol/mmol for 0, 1, 2, 3, and 4–5 components of metabolic syndrome, respectively (p = 0.002). Our data suggest that a reduction of NO bioactivity concur with clustered features of the metabolic syndrome.